MediciNova, a US biopharmaceutical company has been granted a US patent for its new drugs targeting hypertriglyceridemia, hypercholesterolemia and hyperlipoproteinemia. FDA’ has granted fast track designation and Orphan-drug designation for one of these new drugs. For more information, click here.
top of page
Search
Recent Posts
See AllGeneral Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...
Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...
The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...
bottom of page
Commenti